17-AAG

17-N-Allylamino-17-demethoxygeldanamycin

17-N-Allylamino-17-demethoxygeldanamycin
17-N-Allylamino-17-demethoxygeldanamycin is a derivative of the antibiotic geldanamycin that is being studied in the treatment of cancer, specific young patients with certain types of leukemia or solid tumors, especially kidney tumors. It works by targeting Hsp90, which is expressed in those tumors. As of June 2005, 17-N-allylamino-17-demethoxygeldanamycin is undergoing Phase 1 and Phase 2 clinical trials. It belongs to the family of drugs called antitumor antibiotics.

17-AAG - List of case studies

IgG Multiple Myeloma

perifosine ; and the heat shock protein inhibitor 17-AAG . Most of these are available only on clinical trials now. A good ... inhibitor, perifosine, heat shock protein inhibitor, 17-AAG. Treatments : radiotherapy (to the vertebral lesions), Autologus ...

Drugs

V | W | X | # 13-cis-retinoic acid 17-AAG 5-aza-cytabine 5-fluorouracil 5FU A ACE ...

Acute myocardial infarction with ST segment elevation

short_summary:  45-year-old male with recent extensive anterior ST elevation myocardial infarction that was treated by primary PCI, anticoagulation medications and temporary IABP support. Left ...

JustAnswer.com